Optimal perfusion chemotherapy: A prospective comparison of mitomycin C and oxaliplatin for hyperthermic intraperitoneal chemotherapy in metastatic colon cancer.

Matthew R WoestePrejesh PhilipsMichael E EggerCharles R ScogginsKelly M McMastersRobert C G Martin

Published in: Journal of surgical oncology (2020)

MMC or Oxali based HIPEC chemotherapy are both safe and effective for the management of peritoneal only metastatic CRC. Both perfusion therapies should be considered with all patients receiving modern induction chemotherapy.

Keyphrases

locally advanced
squamous cell carcinoma
small cell lung cancer
rectal cancer
computed tomography
magnetic resonance